Le Lézard
Classified in: Health, Science and technology
Subject: ACC

DSM - Repurchase of Shares (10-14 February 2020)


HEERLEN, Netherlands, Feb. 18, 2020 /PRNewswire/ -- Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, has repurchased 238,303 of its own shares in the period from 10 February 2020 up to and including 14 February 2020 at an average price of ?116.31. This is in accordance with the repurchase announced on 21 March 2019, covering the intended reduction of issued capital as well as commitments under share-based compensation plans and for stock dividends. The consideration of this repurchase was ?27.7 million.

DSM Logo (PRNewsFoto/Royal DSM NV) (PRNewsfoto/Royal DSM)

The total number of shares repurchased under this program to date is 9,055,369 shares for a total consideration of ?991.4 million.

For more detailed information see 'Daily transaction details Share Repurchase Program announced 14 March 2019'.

DSM ? Bright Science. Brighter Living.tm

Royal DSM is a global, purpose-led, science-based company active in Nutrition, Health and Sustainable Living. DSM's purpose is to create brighter lives for all. DSM addresses with its products and solutions some of the world's biggest challenges while simultaneously creating economic, environmental and societal value for all its stakeholders ? customers, employees, shareholders, and society at large. DSM delivers innovative solutions for human nutrition, animal nutrition, personal care and aroma, medical devices, green products and applications, and new mobility and connectivity. DSM and its associated companies deliver annual net sales of about ?10 billion with approximately 23,000 employees. The company was founded in 1902 and is listed on Euronext Amsterdam. More information can be found at www.dsm.com.

Or find us on: Facebook | Twitter | LinkedIn | YouTube

Forward-looking statements

This press release may contain forward-looking statements with respect to DSM's future (financial) performance and position. Such statements are based on current expectations, estimates and projections of DSM and information currently available to the company. DSM cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance and position to differ materially from these statements. DSM has no obligation to update the statements contained in this press release, unless required by law. The English language version of the press release is leading.

Logo - https://mma.prnewswire.com/media/657851/DSM_Logo.jpg


These press releases may also interest you

at 15:45
Core Sound Imaging, creator of the Studycast system, today announces that Core Sound Imaging was named a 2024 SIIA CODiE Award Finalist in the Most Innovative Tech Company category. CODiE Finalists represent the best products, services and people in...

at 15:43
Today marks the release of the 2024 National Strategy for Suicide Prevention, an important milestone and rallying point for organizations nationwide working to address this important public health issue. The American Foundation for Suicide Prevention...

at 15:28
A case management hearing in the above-named matter is scheduled to be heard on April 23, 2024 at 4:30 p.m. by videoconference.  Members of the public may observe the hearing by videoconference, by selecting the "Register to attend" link on the...

at 15:14
Cymbiotika, a trailblazer in health and wellness, is thrilled to announce the launch of its new pet line, meticulously crafted to enhance the health and vitality of beloved pets. The new line includes four revolutionary products: Probiotic+, Calm,...

at 15:00
TELUS Health revealed today the results of its 2024 Drug Data Trends and National Benchmarks Report at its 20th annual TELUS Health Conference, running today and April 30. Diabetes medications remain the leading drug category for eligible private...

at 14:45
With safe seated mammography trending in the U.S., the Samuel U. Rodgers Health Center (Sam Rodgers) reports its use of the Danish made VELA Mammography Chair has provided significant physical benefits for patients, health benefits for mammographers,...



News published on and distributed by: